aminoglutethimide has been researched along with etomidate in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Berger, ML; Hahner, S; Hammerschmidt, F; Peric-Simov, B; Schirbel, A; Zolle, IM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Engelhardt, D | 1 |
| Engelhardt, D; Weber, MM | 1 |
| Allolio, B; Beuschlein, F; Fassnacht, M; Hahner, S; Klink, A; Reincke, M | 1 |
| Fleseriu, M; Petersenn, S | 1 |
| Harvey, PW | 1 |
5 review(s) available for aminoglutethimide and etomidate
| Article | Year |
|---|---|
Steroid biosynthesis inhibitors in Cushing's syndrome.
Topics: Adrenal Cortex Hormones; Aminoglutethimide; Cushing Syndrome; Dihydrotestosterone; Etomidate; Humans; Ketoconazole; Metyrapone; Mitotane | 1994 |
Therapy of Cushing's syndrome with steroid biosynthesis inhibitors.
Topics: 3-Hydroxysteroid Dehydrogenases; Aminoglutethimide; Cushing Syndrome; Dihydrotestosterone; Etomidate; Humans; Ketoconazole; Metyrapone; Steroids | 1994 |
New mechanisms of adrenostatic compounds in a human adrenocortical cancer cell line.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Aminoglutethimide; Cell Division; Cholesterol Side-Chain Cleavage Enzyme; Etomidate; Humans; Hydrocortisone; Metyrapone; Receptors, Corticotropin; Receptors, Glucocorticoid; RNA, Messenger; Steroids; Tumor Cells, Cultured | 2000 |
Medical management of Cushing's disease: what is the future?
Topics: Aminoglutethimide; Dopamine Agonists; Drug Therapy, Combination; Etomidate; Humans; Ligands; Mifepristone; Pituitary ACTH Hypersecretion; Pituitary Gland; PPAR gamma; Receptors, Glucocorticoid; Receptors, Somatostatin; Somatostatin | 2012 |
Adrenocortical endocrine disruption.
Topics: Adrenal Cortex; Adrenal Insufficiency; Aminoglutethimide; Animals; Cell Line, Tumor; Corticosterone; Cytochrome P-450 Enzyme System; Disease Models, Animal; Endocrine Disruptors; Etomidate; Gene Expression Regulation; Humans; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Receptors, Corticotropin; Signal Transduction; Stress, Physiological | 2016 |
5 other study(ies) available for aminoglutethimide and etomidate
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
New selective inhibitors of steroid 11beta-hydroxylation in the adrenal cortex. Synthesis and structure-activity relationship of potent etomidate analogues.
Topics: Adrenal Cortex; Animals; Binding Sites; Etomidate; Humans; Hydroxylation; Iodine Radioisotopes; Kinetics; Male; Molecular Structure; Rats; Rats, Wistar; Stereoisomerism; Steroid 11-beta-Hydroxylase; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |